Money & Corp · Court of Appeals for the D.C. Circuit
Aug 18, 2026
AI illustrationTeva Pharmaceuticals challenges drug pricing rules. Did they overstep their authority?
Your callDid the Centers for & Medicaid Services overstep its authority under drug pricing rules?
TL;DR
- 1Teva Pharmaceuticals says that the Centers for & Medicaid Services () incorrectly grouped Austedo and Austedo XR as one drug, impacting their pricing under the new rules.
- 2 counters that their rules follow the , which allows them to treat these similar drugs as one for price negotiations.
- 3The court now has to decide if 's way of grouping drugs is legal and if Teva can challenge this in court.




